ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

MElanoma Research Lymph Node Prediction Implementation National_001

ClinicalTrials.gov ID: NCT04759781

Public ClinicalTrials.gov record NCT04759781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Registry Study of a Primary Melanoma Gene-signature to Predict Sentinel Node (SN) Status and Determine Its Prognostic Value for More Accurate Staging of SN-negative Melanoma Patients.

Study identification

NCT ID
NCT04759781
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
SkylineDx
Industry
Enrollment
1,820 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 24, 2021
Primary completion
Jun 27, 2024
Completion
May 31, 2029
Last update posted
Apr 22, 2026

2021 – 2029

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Moffitt Cancer Center Tampa Florida 33612
Emory University School of Medicine Atlanta Georgia 30322
University of Kentucky Lexington Kentucky 40506
University of Louisville Louisville Kentucky 40292
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55905
Memorial Sloan Kettering Cancer Center New York New York 10065
Duke University Durham North Carolina 27705
Huntsman Cancer Institute Salt Lake City Utah 84112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04759781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04759781 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →